| Michael David Reep, MD | |
|
26908 Detroit Rd, Suite 103, Westlake, OH 44145-2398 | |
| (440) 482-8323 | |
| (440) 808-1606 |
| Full Name | Michael David Reep |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 27 Years |
| Location | 26908 Detroit Rd, Westlake, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578544284 | NPI | - | NPPES |
| 2253654 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 075531R (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associates In Dermatology, Inc. | 2668495409 | 9 |
News Archive
Exercising more than once a week after 50 years of age is linked to a 60% lower risk of COVID-19 hospitalization. An international team of researchers has found that physical activity involving muscle training can be protective against severe infection.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today an interim analysis of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in infants and children 6 months through 9 years of age. The data indicate the vaccine is immunogenic and that one dose may protect many children.
Pten (short for phosphatase and tensin homolog) is a tumor suppressor that is defective in about 20-25 percent of all patients with cancers. Mayo Clinic researchers now have discovered that Pten safeguards against tumor formation by keeping chromosome numbers intact when a cell splits into two daughter cells.
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
› Verified 5 days ago
| Entity Name | Associates In Dermatology, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396852133 PECOS PAC ID: 2668495409 Enrollment ID: O20060109000134 |
News Archive
Exercising more than once a week after 50 years of age is linked to a 60% lower risk of COVID-19 hospitalization. An international team of researchers has found that physical activity involving muscle training can be protective against severe infection.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today an interim analysis of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in infants and children 6 months through 9 years of age. The data indicate the vaccine is immunogenic and that one dose may protect many children.
Pten (short for phosphatase and tensin homolog) is a tumor suppressor that is defective in about 20-25 percent of all patients with cancers. Mayo Clinic researchers now have discovered that Pten safeguards against tumor formation by keeping chromosome numbers intact when a cell splits into two daughter cells.
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael David Reep, MD 26908 Detroit Rd, Suite 103, Westlake, OH 44145-2398 Ph: (440) 482-8323 | Michael David Reep, MD 26908 Detroit Rd, Suite 103, Westlake, OH 44145-2398 Ph: (440) 482-8323 |
News Archive
Exercising more than once a week after 50 years of age is linked to a 60% lower risk of COVID-19 hospitalization. An international team of researchers has found that physical activity involving muscle training can be protective against severe infection.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today an interim analysis of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in infants and children 6 months through 9 years of age. The data indicate the vaccine is immunogenic and that one dose may protect many children.
Pten (short for phosphatase and tensin homolog) is a tumor suppressor that is defective in about 20-25 percent of all patients with cancers. Mayo Clinic researchers now have discovered that Pten safeguards against tumor formation by keeping chromosome numbers intact when a cell splits into two daughter cells.
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
› Verified 5 days ago
Aziza A Wahby, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4350 Crocker Rd Ste 300, Westlake, OH 44145 Phone: 440-646-1600 Fax: 440-646-1505 | |
Mihir Minesh Shah, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 26908 Detroit Rd Ste 103, Westlake, OH 44145 Phone: 440-249-0274 Fax: 440-808-1718 | |
Dr. James M Kasick, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 29099 Health Campus Dr, Suite 330, Westlake, OH 44145 Phone: 440-835-6278 Fax: 440-835-6278 | |
Dr. Louis Stephen Kish, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 26410 Center Ridge Rd, Westlake, OH 44145 Phone: 440-835-6194 Fax: 440-892-9160 | |
Dr. Renuka Diwan, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 29101 Health Campus Dr, Suite 300, Westlake, OH 44145 Phone: 440-871-9832 Fax: 440-871-0816 | |
Conley Walter Engstrom, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 26908 Detroit Rd, Suite 103, Westlake, OH 44145 Phone: 440-482-8323 Fax: 440-808-1606 |